Ausgabe 1/2016
Inhalt (21 Artikel)
Progestin and breast cancer risk: a systematic review
Marsha Samson, Nancy Porter, Olubunmi Orekoya, James R. Hebert, Swann Arp Adams, Charles L. Bennett, Susan E. Steck
Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer
M. T. Branham, E. Campoy, S. Laurito, R. Branham, G. Urrutia, J. Orozco, F. Gago, R. Urrutia, M. Roqué
Clinical utility of reverse phase protein array for molecular classification of breast cancer
Ola H. Negm, Abir A. Muftah, Mohammed A. Aleskandarany, Mohamed R. Hamed, Dena A. J. Ahmad, Christopher C. Nolan, Maria Diez-Rodriguez, Patrick J. Tighe, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
184AA3: a xenograft model of ER+ breast adenocarcinoma
William C. Hines, Irene Kuhn, Kate Thi, Berbie Chu, Gaelen Stanford-Moore, Rocío Sampayo, James C. Garbe, Martha Stampfer, Alexander D. Borowsky, Mina J. Bissell
Survivin contributes to DNA repair by homologous recombination in breast cancer cells
Eloïse Véquaud, Grégoire Desplanques, Pascal Jézéquel, Philippe Juin, Sophie Barillé-Nion
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets
Saki Nakagawa, Yasuhiro Miki, Minoru Miyashita, Shuko Hata, Yayoi Takahashi, Yoshiaki Rai, Yasuaki Sagara, Yasuyo Ohi, Hisashi Hirakawa, Kentaro Tamaki, Takanori Ishida, Mika Watanabe, Takashi Suzuki, Noriaki Ohuchi, Hironobu Sasano
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
C. Jacobs, I. Kuchuk, N. Bouganim, S. Smith, S. Mazzarello, L. Vandermeer, G. Dranitsaris, S. Dent, S. Gertler, S. Verma, X. Song, S. Simos, D. Cella, M. Clemons
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype
Werner Schroth, S. Winter, F. Büttner, S. Goletz, S. Faißt, F. Brinkmann, P. Saladores, E. Heidemann, G. Ott, A. Gerteis, M. D. Alscher, J. Dippon, M. Schwab, H. Brauch, P. Fritz
Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Hidenori Arai, Akira Mitani, Tadao Tsuboyama
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Thomas Kolben, D. Augustin, R. Armbrust, T. M. Kolben, T. Degenhardt, M. Burgmann, C. Goess, N. Ditsch, R. Kates, N. Harbeck, R. Wuerstlein
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial
Lucia Del Mastro, Alessia Levaggi, Andrea Michelotti, Giovanna Cavazzini, Francesca Adami, Tiziana Scotto, Margherita Piras, Saverio Danese, Ornella Garrone, Antonio Durando, Valeria Accortanzo, Claudia Bighin, Loredana Miglietta, Simona Pastorino, Paolo Pronzato, Federico Castiglione, Elisabetta Landucci, PierFranco Conte, Paolo Bruzzi
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, Magalie Krieguer, Ian Smith, Jose Baselga, David Cameron, Michael Untch, Christian Jackisch, Richard Bell, Luca Gianni, Aron Goldhirsch, Martine Piccart, Richard D. Gelber
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel
Tamar Yablonski-Peretz, Shani Paluch-Shimon, Lior Soussan Gutman, Yulia Kaplan, Addie Dvir, Inbal Barnes-Kedar, Luna Kadouri, Valeriya Semenisty, Noa Efrat, Victoria Neiman, Yafit Glasser, Rachel Michaelson-Cohen, Lior Katz, Bella Kaufman, Talia Golan, Orit Reish, Ayala Hubert, Tamar Safra, Yuval Yaron, Eitan Friedman
Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients
Diana H. Liang, Joe E. Ensor, Zhe-bin Liu, Asmita Patel, Tejal A. Patel, Jenny C. Chang, Angel A. Rodriguez
The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom
Nina Schimdt, Louis Jacob, Robert Coleman, Karel Kostev, Peyman Hadji
Metastatic breast cancer patients: attitudes toward tissue donation for rapid autopsy
Tala Achkar, John Wilson, Jacqueline Simon, Margaret Rosenzweig, Shannon Puhalla
Rates of BRCA1/2 mutation testing among young survivors of breast cancer
Kenneth L. Kehl, Chan Shen, Jennifer K. Litton, Banu Arun, Sharon H. Giordano
The relationship between local recurrence and death in early-stage breast cancer
Victoria Sopik, Sharon Nofech-Mozes, Ping Sun, Steven A. Narod
Factors associated with radiation therapy incompletion for patients with early-stage breast cancer
Rachel A. Freedman, Stacey A. Fedewa, Rinaa S. Punglia, Chun Chieh Lin, Elizabeth M. Ward, Ahmedin Jemal, Helmneh M. Sineshaw
The therapy with negative pressure as a valid device to treat chronic breast infections
Tommaso Fogacci, Federico Cattin, Domenico Samorani